期刊
BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY
卷 76, 期 -, 页码 83-95出版社
ELSEVIER SCI LTD
DOI: 10.1016/j.bpobgyn.2021.03.008
关键词
Pregnancy; Vaccination; Immunization; Immunization programs; Implementation science; Health knowledge; attitudes; practice
资金
- University of Calgary Aca-demic Alternate Relationship Plan
Vaccination in pregnancy (VIP) offers dual benefits for mothers and babies, but uptake rates are low in many countries, with vaccine hesitancy being a major issue. Lack of provider recommendations, safety concerns, and access limitations are the main barriers to VIP.
Vaccination in pregnancy (VIP) is dually beneficial it protects the mother and the baby from tetanus, influenza, and pertussis. VIP uptake is low in many countries. Vaccine hesitancy, defined by the World Health Organization (WHO) as a delay in acceptance or refusal of vaccination despite the availability of vaccination services is one of WHO's ten threats to global health per 2019. According to extensive research, mostly from high-income countries (HIC) and limited to tetanus, influenza and pertussis vaccines, lack of provider recommendations, safety concerns, and limitations in access are the main barriers to VIP. Health care provider recommendation is the leading facilitator for VIP across various socioeconomic status groups. Data on strategies to overcome patient, provider, and system barriers to VIP are inconsistent, contradictory, or lacking. Patient focused research on evidence-based strategies to overcome provider and system barriers is needed. Furthermore, VIP programs require embedded continuous quality improvement to ensure sustainability. (c) 2021 Published by Elsevier Ltd.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据